Skinvisible Inc (SKVI) financial statements (2022 and earlier)

Company profile

Business Address 6320 S SANDHILL ROAD
LAS VEGAS, NV 89120
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments66495513361135
Cash and cash equivalents66495513361135
Receivables056781119
Other undisclosed current assets8473742
Total current assets:74586822502656
Noncurrent Assets
Intangible assets, net (including goodwill)153158162146150158160
Intangible assets, net (excluding goodwill)153158162146150158160
Total noncurrent assets:153158162146150158160
TOTAL ASSETS:227216231169200184217
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,0401,034986952865843759
Interest and dividends payable1,4751,3101,2001,1401,021890762
Other undisclosed accounts payable and accrued liabilities(435)(276)(215)(188)(156)(48)(3)
Due to related parties27525252525959
Other undisclosed current liabilities1,9942,0222,0321,9531,8011,6751,546
Total current liabilities:3,0613,1083,0702,9582,7192,5762,364
Noncurrent Liabilities
Long-term debt and lease obligation   220220  
Long-term debt, excluding current maturities   220220  
Other undisclosed noncurrent liabilities2,5822,4162,2661,8811,7161,7671,602
Total noncurrent liabilities:2,5822,4162,2662,1011,9361,7671,602
Total liabilities:5,6435,5255,3365,0594,6554,3443,967
Stockholders' equity
Stockholders' equity attributable to parent, including:(5,416)(5,309)(5,105)(4,890)(4,455)(4,160)(3,750)
Common stock5555554
Additional paid in capital30,35330,29430,29430,24130,24130,24130,182
Accumulated deficit(35,773)(35,608)(35,404)(35,136)(34,700)(34,405)(33,996)
Other additional capital 5353    
Other undisclosed stockholders' equity attributable to parent (53)(53)   60
Total stockholders' equity:(5,416)(5,309)(5,105)(4,890)(4,455)(4,160)(3,750)
TOTAL LIABILITIES AND EQUITY:227216231169200184217

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues663 2871213149
Revenue from related parties    23111
Cost of revenue   (3)   
Other undisclosed gross profit(411)111  23111
Gross profit:25311128791337120
Operating expenses(105)(119)(128)(120)(125)(125)(133)
Other operating expense, net
(Other Expenses)
(1,261)  (324)(303)(291)(300)
Other undisclosed operating income1,261  324303291300
Operating income (loss):148(8)160(111)8(119)(13)
Interest and debt expense(320)(275)(225)(284)(303)(291)(300)
Net loss:(172)(283)(65)(395)(295)(410)(313)
Other undisclosed net income (loss) attributable to parent779(204)(40)   
Net loss available to common stockholders, diluted:(165)(203)(269)(436)(295)(410)(313)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(172)(283)(65)(395)(295)(410)(313)
Comprehensive loss, net of tax, attributable to parent:(172)(283)(65)(395)(295)(410)(313)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: